| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +18.6% |
| R&D Expense | $866K | +431.4% |
| SG&A Expense | $13.3M | +76.4% |
| Operating Income | -$23.3M | -253.1% |
| Interest Expense | $68K | — |
| Pre-tax Income | -$23.0M | -539.8% |
| Income Tax | -$425K | — |
| Net Income | -$16.8M | -387.8% |
| EPS (Basic) | -$0.42 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.2M | +263.0% |
| Short-term Investments | $8.8M | -84.4% |
| Accounts Receivable | $709K | +33.9% |
| Current Assets | $94.7M | +20.9% |
| Total Assets | $112.7M | +0.6% |
| Current Liabilities | $30.5M | +155.0% |
| Total Liabilities | $35.2M | +88.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | -20.0% |
| Capital Expenditures | $83K | -78.1% |
| Investing Cash Flow | $23.8M | +288.5% |
| Financing Cash Flow | $23.9M | +234.8% |
| Free Cash Flow | -$9.9M | -15.7% |
| -320.0% |
| EPS (Diluted) | -$0.42 | -320.0% |
| Stockholders' Equity |
| $73.0M |
| -11.8% |